Trgovina Ionis Pharmaceuticals, Inc. - IONS CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.20 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ionis Pharmaceuticals Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 40.6 |
Odpri* | 40.78 |
Enoletna sprememba* | 8.52% |
Dnevni razpon* | 40.17 - 41.38 |
Razpon 52 wk | 32.69-48.82 |
Povprečni obseg (10 dni) | 1.38M |
Povprečni obseg (3 meseci) | 20.88M |
Tržna kapitalizacija | 5.83B |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 143.09M |
Prihodki | 575.97M |
EPS | -2.31 |
Dividenda (donosnost v %) | N/A |
Beta | 0.53 |
Datum naslednjega zaslužka | Aug 7, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 40.60 | 2.27 | 5.92% | 38.33 | 40.83 | 38.33 |
May 25, 2023 | 39.13 | -0.39 | -0.99% | 39.52 | 41.57 | 38.89 |
May 24, 2023 | 41.24 | -0.58 | -1.39% | 41.82 | 42.47 | 41.09 |
May 23, 2023 | 42.16 | 1.62 | 4.00% | 40.54 | 43.42 | 40.54 |
May 22, 2023 | 40.61 | 1.75 | 4.50% | 38.86 | 40.81 | 37.78 |
May 19, 2023 | 39.02 | 3.61 | 10.19% | 35.41 | 39.31 | 35.41 |
May 18, 2023 | 36.58 | 2.03 | 5.88% | 34.55 | 36.70 | 34.55 |
May 17, 2023 | 36.13 | 1.42 | 4.09% | 34.71 | 36.29 | 34.70 |
May 16, 2023 | 35.79 | 0.93 | 2.67% | 34.86 | 35.96 | 34.81 |
May 15, 2023 | 36.09 | 0.68 | 1.92% | 35.41 | 36.39 | 34.70 |
May 12, 2023 | 35.38 | 0.05 | 0.14% | 35.33 | 35.68 | 35.16 |
May 11, 2023 | 35.48 | 0.79 | 2.28% | 34.69 | 35.72 | 34.69 |
May 10, 2023 | 35.69 | 0.86 | 2.47% | 34.83 | 36.65 | 34.83 |
May 9, 2023 | 35.57 | 0.81 | 2.33% | 34.76 | 36.18 | 34.51 |
May 8, 2023 | 35.18 | -0.28 | -0.79% | 35.46 | 35.88 | 34.81 |
May 5, 2023 | 36.06 | 0.94 | 2.68% | 35.12 | 36.55 | 34.80 |
May 4, 2023 | 35.87 | 1.30 | 3.76% | 34.57 | 36.16 | 34.03 |
May 3, 2023 | 34.56 | -0.83 | -2.35% | 35.39 | 36.23 | 33.52 |
May 2, 2023 | 35.35 | 0.59 | 1.70% | 34.76 | 35.78 | 34.11 |
May 1, 2023 | 35.62 | 0.79 | 2.27% | 34.83 | 36.00 | 34.43 |
Ionis Pharmaceuticals, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Thursday, June 1, 2023 | ||
Čas (UTC) (UTC) 21:00 | Država US
| Dogodek Ionis Pharmaceuticals Inc Annual Shareholders Meeting Ionis Pharmaceuticals Inc Annual Shareholders MeetingForecast -Previous - |
Friday, June 2, 2023 | ||
Čas (UTC) (UTC) 21:00 | Država US
| Dogodek Ionis Pharmaceuticals Inc Annual Shareholders Meeting Ionis Pharmaceuticals Inc Annual Shareholders MeetingForecast -Previous - |
Monday, June 12, 2023 | ||
Čas (UTC) (UTC) 16:20 | Država US
| Dogodek Ionis Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Ionis Pharmaceuticals Inc at Goldman Sachs Healthcare ConferenceForecast -Previous - |
Monday, August 7, 2023 | ||
Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q2 2023 Ionis Pharmaceuticals Inc Earnings Release Q2 2023 Ionis Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
Tuesday, November 7, 2023 | ||
Čas (UTC) (UTC) 13:30 | Država US
| Dogodek Q3 2023 Ionis Pharmaceuticals Inc Earnings Release Q3 2023 Ionis Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 587.367 | 810.456 | 729.264 | 1122.6 | 599.674 |
Prihodki | 587.367 | 810.456 | 729.264 | 1122.6 | 599.674 |
Celotni stroški prihodkov | 14.116 | 10.842 | 11.947 | 4.384 | 1.82 |
Bruto dobiček | 573.251 | 799.614 | 717.317 | 1118.21 | 597.854 |
Celotni odhodki iz poslovanja | 997.558 | 849.269 | 901.346 | 822.912 | 661.046 |
Celotna prodaja/splošni/upravni stroški Odhodki | 150.295 | 170.947 | 332.222 | 286.644 | 244.622 |
Raziskave in razvoj | 833.147 | 634.953 | 526.877 | 465.688 | 414.604 |
Nenavadni odhodki (prihodki) | 32.527 | 30.3 | 66.196 | 0 | |
Prihodki iz poslovanja | -410.191 | -38.813 | -172.082 | 299.687 | -61.372 |
Prihodki (odhodki) od obresti, neto Neoperativni | 9.876 | 10.798 | 37.592 | 39.765 | -14.602 |
Drugo, neto | -7.274 | -1.133 | -0.062 | -0.686 | -0.182 |
Čisti dobiček pred obdavčitvijo | -257.985 | -29.148 | -134.552 | 338.766 | -76.156 |
Čisti dobiček po davkih | -269.722 | -28.597 | -479.743 | 287.259 | -117.115 |
Manjšinski delež | 0 | 0 | 35.48 | -9.116 | 58.756 |
Čisti dobiček pred dodatnimi postavkami | -269.722 | -28.597 | -444.263 | 278.143 | -58.359 |
Čisti dobiček | -269.722 | -28.597 | -444.263 | 278.143 | 273.741 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -269.722 | -28.597 | -444.263 | 278.143 | -58.359 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -269.722 | -28.597 | -444.263 | 278.143 | 273.741 |
Prilagoditev za redčenje | 0 | ||||
Popravljen čisti dobiček | -269.722 | -28.597 | -444.263 | 278.143 | 273.741 |
Popravljene ponderirane povprečne delnice | 141.848 | 141.021 | 139.612 | 153.164 | 134.056 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.90149 | -0.20279 | -3.18213 | 1.81598 | -0.43533 |
Popravljen normalizirani dobiček na enoto čistega dobička | -2.58703 | -0.05286 | -3.04106 | 2.18246 | -0.43533 |
Skupaj izredne postavke | 332.1 | ||||
Gain (Loss) on Sale of Assets | 149.604 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 130.524 | 151.889 | 159.767 | 133.791 | 141.919 |
Prihodki | 130.524 | 151.889 | 159.767 | 133.791 | 141.919 |
Celotni stroški prihodkov | 1.343 | 3.686 | 1.515 | 4.745 | 4.17 |
Bruto dobiček | 129.181 | 148.203 | 158.252 | 129.046 | 137.749 |
Celotni odhodki iz poslovanja | 244.672 | 359.908 | 218.921 | 219.305 | 199.423 |
Celotna prodaja/splošni/upravni stroški Odhodki | 45.516 | 47.95 | 34.416 | 33.802 | 34.127 |
Raziskave in razvoj | 197.813 | 308.272 | 182.99 | 180.758 | 161.126 |
Prihodki iz poslovanja | -114.148 | -208.019 | -59.154 | -85.514 | -57.504 |
Prihodki (odhodki) od obresti, neto Neoperativni | 16.49 | 13.436 | 7.732 | -5.064 | -6.754 |
Drugo, neto | -15.285 | 0.649 | 4.713 | -12.297 | 0.187 |
Čisti dobiček pred obdavčitvijo | -112.943 | -44.33 | -46.709 | -102.875 | -64.071 |
Čisti dobiček po davkih | -124.323 | -52.43 | -46.992 | -105.135 | -65.165 |
Manjšinski delež | 0 | ||||
Čisti dobiček pred dodatnimi postavkami | -124.323 | -52.43 | -46.992 | -105.135 | -65.165 |
Čisti dobiček | -124.323 | -52.43 | -46.992 | -105.135 | -65.165 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -124.323 | -52.43 | -46.992 | -105.135 | -65.165 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -124.323 | -52.43 | -46.992 | -105.135 | -65.165 |
Popravljen čisti dobiček | -124.323 | -52.43 | -46.992 | -105.135 | -65.165 |
Popravljene ponderirane povprečne delnice | 142.735 | 142.046 | 141.95 | 141.794 | 141.599 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.87101 | -0.36911 | -0.33105 | -0.74146 | -0.46021 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.87101 | -1.05369 | -0.33105 | -0.74146 | -0.46021 |
Nenavadni odhodki (prihodki) | |||||
Gain (Loss) on Sale of Assets | 149.604 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 2202.69 | 2345.05 | 2130.71 | 2720.6 | 2207.89 |
Denarna sredstva in kratkoročne naložbe | 1986.87 | 2114.97 | 1892.38 | 2499.54 | 2084.07 |
Denarna sredstva in ustrezniki | 276.472 | 869.191 | 397.664 | 683.287 | 278.82 |
Kratkoročne naložbe | 1710.4 | 1245.78 | 1494.71 | 1816.26 | 1805.25 |
Celotne terjatve, neto | 25.538 | 61.896 | 76.204 | 63.034 | 12.759 |
Accounts Receivable - Trade, Net | 25.538 | 61.896 | 76.204 | 63.034 | 12.759 |
Total Inventory | 22.033 | 24.806 | 21.965 | 18.18 | 8.582 |
Other Current Assets, Total | 168.254 | 143.374 | 140.163 | 139.839 | 102.473 |
Total Assets | 2533.88 | 2611.69 | 2389.75 | 3233.11 | 2667.78 |
Property/Plant/Equipment, Total - Net | 255.838 | 196.069 | 181.077 | 166.251 | 132.16 |
Property/Plant/Equipment, Total - Gross | 343.554 | 298.722 | 240.264 | 193.634 | |
Accumulated Depreciation, Total | -87.716 | -102.653 | -74.013 | -61.474 | |
Intangibles, Net | 29.005 | 27.937 | 25.674 | 24.032 | |
Other Long Term Assets, Total | 75.344 | 41.567 | 50.034 | 320.59 | 303.706 |
Total Current Liabilities | 311.561 | 240.55 | 598.898 | 273.005 | 280.294 |
Accounts Payable | 17.921 | 11.904 | 17.199 | 16.067 | 28.66 |
Accrued Expenses | 196.494 | 129.97 | 155.889 | 106.152 | 77.629 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.32 | 0.926 | 316.11 | 13.749 | |
Other Current Liabilities, Total | 96.826 | 97.75 | 109.7 | 150.786 | 160.256 |
Total Liabilities | 1960.99 | 1839.95 | 1646.47 | 1762.02 | 1619.7 |
Total Long Term Debt | 1182.72 | 1228.02 | 623.529 | 770.3 | 632.971 |
Long Term Debt | 1182.72 | 1228.02 | 623.529 | 770.3 | 632.971 |
Capital Lease Obligations | |||||
Other Liabilities, Total | 466.709 | 371.379 | 424.046 | 505.26 | 567.359 |
Total Equity | 572.887 | 771.737 | 743.282 | 1471.09 | 1048.08 |
Common Stock | 0.142 | 0.141 | 0.14 | 0.14 | 0.138 |
Additional Paid-In Capital | 2059.85 | 1964.17 | 1895.52 | 2203.78 | 2047.25 |
Retained Earnings (Accumulated Deficit) | -1429.62 | -1159.9 | -1131.31 | -707.534 | -967.293 |
Other Equity, Total | -57.48 | -32.668 | -21.071 | -25.29 | -32.016 |
Total Liabilities & Shareholders’ Equity | 2533.88 | 2611.69 | 2389.75 | 3233.11 | 2667.78 |
Total Common Shares Outstanding | 142.058 | 141.21 | 140.366 | 140.34 | 137.929 |
Minority Interest | 213.453 | 139.081 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 2542.62 | 2202.69 | 2152.13 | 2191.15 | 2253.12 |
Denarna sredstva in kratkoročne naložbe | 2346.78 | 1986.87 | 1981.66 | 2021.83 | 2052.39 |
Denarna sredstva in ustrezniki | 309.031 | 276.472 | 314.993 | 521.917 | 542.513 |
Kratkoročne naložbe | 2037.75 | 1710.4 | 1666.67 | 1499.91 | 1509.88 |
Celotne terjatve, neto | 13.914 | 25.538 | 6.645 | 6.751 | 26.122 |
Accounts Receivable - Trade, Net | 13.914 | 25.538 | 6.645 | 6.751 | 26.122 |
Total Inventory | 22.2 | 22.033 | 20.645 | 19.811 | 24.032 |
Other Current Assets, Total | 159.724 | 168.254 | 143.173 | 142.759 | 150.577 |
Total Assets | 2885.22 | 2533.88 | 2421.97 | 2456.13 | 2519.09 |
Property/Plant/Equipment, Total - Net | 264.306 | 255.838 | 180.806 | 177.015 | 177.724 |
Intangibles, Net | 29.605 | 29.054 | 29.295 | ||
Other Long Term Assets, Total | 78.296 | 75.344 | 59.434 | 58.916 | 58.949 |
Total Current Liabilities | 259.221 | 311.561 | 283.454 | 267.811 | 228.45 |
Accounts Payable | 10.499 | 17.921 | 20.545 | 10.351 | 16.125 |
Accrued Expenses | 130.862 | 189.279 | 158.412 | 159.321 | 115.781 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 8.239 | 7.535 | 4.97 | 4.732 | 4.206 |
Other Current Liabilities, Total | 109.621 | 96.826 | 99.527 | 93.407 | 92.338 |
Total Liabilities | 2398.65 | 1960.99 | 1827.61 | 1831.41 | 1809.52 |
Total Long Term Debt | 1184.38 | 1182.72 | 1249.5 | 1248.4 | 1247.93 |
Long Term Debt | 1184.38 | 1182.72 | 1249.5 | 1248.4 | 1247.93 |
Other Liabilities, Total | 955.054 | 466.709 | 294.656 | 315.196 | 333.138 |
Total Equity | 486.57 | 572.887 | 594.361 | 624.726 | 709.574 |
Common Stock | 0.143 | 0.142 | 0.142 | 0.142 | 0.142 |
Additional Paid-In Capital | 2089.36 | 2059.85 | 2034.55 | 2008.79 | 1983.08 |
Retained Earnings (Accumulated Deficit) | -1553.95 | -1429.62 | -1377.19 | -1330.2 | -1225.07 |
Other Equity, Total | -48.983 | -57.48 | -63.14 | -54.007 | -48.578 |
Total Liabilities & Shareholders’ Equity | 2885.22 | 2533.88 | 2421.97 | 2456.13 | 2519.09 |
Total Common Shares Outstanding | 143.023 | 142.058 | 142.017 | 141.831 | 141.753 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -269.722 | -28.597 | -479.743 | 287.259 | 214.985 |
Denarna sredstva iz poslovanja | -274.37 | 30.799 | 35.892 | 345.627 | 602.906 |
Denarna sredstva iz poslovanja | 14.328 | 15.487 | 13.365 | 12.54 | 10.706 |
Amortization | 2.415 | 2.352 | 2.064 | 1.912 | 1.822 |
Deferred Taxes | 0 | 0 | 341.729 | 0.911 | -290.516 |
Nedenarne postavke | -28.962 | 155.375 | 232.032 | 211.806 | 166.484 |
Denarna sredstva Plačane obresti | 2.898 | 4.778 | 6.247 | 9.87 | 9.592 |
Spremembe v obratnem kapitalu | 7.571 | -113.818 | -73.555 | -168.801 | 499.425 |
Denarna sredstva pri naložbenju | -262.636 | 194.906 | 274.477 | -41.274 | -929.563 |
Kapitalski izdatki | -15.721 | -11.955 | -35.12 | -30.905 | -13.608 |
Celotne druge postavke denarnih tokov pri naložbenju | -246.915 | 206.861 | 309.597 | -10.369 | -915.955 |
Denarna sredstva pri financiranju | -55.295 | 245.933 | -596.609 | 100.021 | 475.865 |
Postavke denarnega toka pri financiranju | -10.982 | -168.954 | -558.097 | -138.354 | 0 |
Izdaja (odplačilo) delnic, neto | 6.373 | 101.317 | -38.512 | 141.375 | 475.865 |
Izdaja (odplačilo) dolga, neto | -50.686 | 313.57 | 0 | 97 | 0 |
Neto sprememba denarnih sredstev | -592.719 | 471.527 | -285.623 | 404.467 | 149.19 |
Cash Taxes Paid | 5.01 | 0.038 | 25.855 | 9.041 | 0 |
Učinki deviznih tečajev | -0.418 | -0.111 | 0.617 | 0.093 | -0.018 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -124.323 | -269.722 | -217.292 | -170.3 | -65.165 |
Cash From Operating Activities | -133.992 | -274.37 | -74.175 | -49.746 | -31.65 |
Cash From Operating Activities | 2.604 | 14.328 | 11.301 | 7.484 | 3.701 |
Amortization | 0.607 | 2.415 | 1.805 | 1.197 | 0.592 |
Deferred Taxes | 0 | ||||
Non-Cash Items | 42.124 | -28.962 | 91.563 | 64.125 | 32.983 |
Cash Taxes Paid | 0.293 | 5.01 | 0.002 | 0.002 | 0.002 |
Cash Interest Paid | 0.089 | 2.898 | 2.204 | 1.544 | 0.594 |
Changes in Working Capital | -55.004 | 7.571 | 38.448 | 47.748 | -3.761 |
Cash From Investing Activities | -325.64 | -262.636 | -474.783 | -290.853 | -287.549 |
Capital Expenditures | -10.472 | -15.721 | -11.582 | -6.04 | -2.705 |
Other Investing Cash Flow Items, Total | -315.168 | -246.915 | -463.201 | -284.813 | -284.844 |
Cash From Financing Activities | 492.087 | -55.295 | -4.276 | -6.11 | -7.325 |
Financing Cash Flow Items | 489.566 | -10.982 | -10.217 | -9.572 | -9.173 |
Issuance (Retirement) of Stock, Net | 2.56 | 6.373 | 6.03 | 3.462 | 1.848 |
Foreign Exchange Effects | 0.104 | -0.418 | -0.964 | -0.565 | -0.154 |
Net Change in Cash | 32.559 | -592.719 | -554.198 | -347.274 | -326.678 |
Issuance (Retirement) of Debt, Net | -0.039 | -50.686 | -0.089 | 0 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 14.9808 | 21436334 | 128815 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.7482 | 13948885 | 429096 | 2023-03-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 9.1298 | 13064047 | 1385788 | 2023-03-31 | MED |
Bellevue Asset Management AG | Investment Advisor | 6.6474 | 9511900 | -232000 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.9323 | 7057705 | -70015 | 2023-03-31 | LOW |
ClearBridge Investments, LLC | Investment Advisor/Hedge Fund | 3.7679 | 5391581 | -34061 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.8432 | 4068334 | -150395 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.6508 | 3793044 | -359563 | 2023-03-31 | LOW |
Tweedy, Browne Company LLC | Investment Advisor | 2.4747 | 3541046 | -90 | 2023-03-31 | LOW |
Deep Track Capital LP | Hedge Fund | 1.9806 | 2834069 | 1628296 | 2023-03-31 | MED |
ARK Investment Management LLC | Investment Advisor | 1.843 | 2637192 | -36346 | 2023-03-31 | LOW |
BVF Partners L.P. | Hedge Fund | 1.7896 | 2560761 | 1438952 | 2023-03-31 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 1.4847 | 2124500 | 130900 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.4466 | 2069950 | 57227 | 2023-03-31 | LOW |
Camber Capital Management LP | Hedge Fund | 1.3453 | 1925000 | 0 | 2023-03-31 | MED |
First Trust Advisors L.P. | Investment Advisor | 1.1454 | 1638943 | -141990 | 2023-03-31 | LOW |
Macquarie Investment Management | Investment Advisor | 1.044 | 1493903 | 2216 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9062 | 1296647 | 511086 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.8291 | 1186393 | -69875 | 2023-03-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.7778 | 1113042 | 739456 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ionis Pharmaceuticals Company profile
O družbi Ionis Pharmaceuticals, Inc.
Družba Ionis Pharmaceuticals, Inc., se ukvarja z odkrivanjem in razvojem terapij, usmerjenih v ribonukleinske kisline (RNK). Družba se osredotoča predvsem na svoje franšize za kardiovaskularno in nevrološko področje. Med njenimi izdelki so SPINRAZA, TEGSEDI in WAYLIVRA. Zdravilo SPINRAZA je namenjeno zdravljenju bolnikov vseh starosti s spinalno mišično atrofijo (SMA), progresivno, izčrpavajočo in pogosto usodno genetsko boleznijo. Zdravilo TEGSEDI je namenjeno zdravljenju bolnikov s polinevropatijo, ki jo povzroča dedni transtiretin (TTR), amiloidoza (hATTR), izčrpavajoča, napredujoča in usodna bolezen. WAYLIVRA je protisenzorično zdravilo, indicirano kot dodatek k prehrani pri odraslih bolnikih. Družba ima več kot šest zdravil v študijah faze III za osem indikacij, med katerimi so Eplontersen (TTR), Olezarsen (ApoC-III), Donidalorsen (PKK), ION363 (FUS), Pelacarsen (Apo(a)) in Tofersen (SOD1). Njegova zdravila za srce in ožilje v razvoju vključujejo zdravila Eplontersen, Olezarsen, Pelacarsen, ION449 (PCSK9), Fesomersen in IONIS-AGT-LRx.
Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com